UroGen Pharma Ltd (URGN)
14.15
+0.33
(+2.39%)
USD |
NASDAQ |
Apr 26, 16:00
14.13
-0.02
(-0.14%)
After-Hours: 20:00
UroGen Pharma Cash from Operations (TTM): -76.38M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -76.38M |
| September 30, 2023 | -85.13M |
| June 30, 2023 | -85.44M |
| March 31, 2023 | -89.37M |
| December 31, 2022 | -87.56M |
| September 30, 2022 | -85.88M |
| June 30, 2022 | -86.74M |
| March 31, 2022 | -81.49M |
| December 31, 2021 | -84.89M |
| September 30, 2021 | -86.06M |
| June 30, 2021 | -92.67M |
| March 31, 2021 | -97.65M |
| December 31, 2020 | -105.89M |
| Date | Value |
|---|---|
| September 30, 2020 | -110.64M |
| June 30, 2020 | -98.09M |
| March 31, 2020 | -88.72M |
| December 31, 2019 | -71.02M |
| September 30, 2019 | -55.30M |
| June 30, 2019 | -52.05M |
| March 31, 2019 | -45.64M |
| December 31, 2018 | -37.33M |
| September 30, 2018 | -33.01M |
| June 30, 2018 | -21.13M |
| March 31, 2018 | -16.45M |
| December 31, 2017 | -9.568M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-110.64M
Minimum
Sep 2020
-52.05M
Maximum
Jun 2019
-85.31M
Average
-86.06M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Agenus Inc | -224.20M |
| Exelixis Inc | 333.32M |
| Geron Corp | -167.74M |
| Protalix BioTherapeutics Inc | -1.318M |
| InfuSystems Holdings Inc | 11.22M |